1. Abstract 14688: TREK-1 Modulates Fibrosis & Diastolic Dysfunction Through Activation of Stress-Activated Kinases
- Author
-
Teresa E. Lee, Lewis J. Watson, Matthew J. Wolf, Dennis M. Abraham, Gurangad S. Chandok, Lan Mao, and Howard A. Rockman
- Subjects
Pressure overload ,Cardiac function curve ,endocrine system ,medicine.medical_specialty ,Cardiac fibrosis ,business.industry ,Diastole ,Concentric hypertrophy ,medicine.disease ,Fibroblast migration ,Endocrinology ,Fibrosis ,Physiology (medical) ,Internal medicine ,medicine ,Cardiology and Cardiovascular Medicine ,business ,Heart failure with preserved ejection fraction ,human activities - Abstract
Introduction: Heart failure with preserved ejection fraction (HFpEF) is a major public health problem because of its high prevalence and the current lack of effective therapies. HFpEF is thought to develop through diastolic dysfunction caused by diminished ventricular compliance, which is strongly influenced by cardiac fibrosis. Our work identifies TWIK related potassium channel-1 (TREK-1) as a novel modulator of diastolic dysfunction and cardiac fibrosis. Methods & Results: TREK-1 is expressed in mammalian cardiac tissue, although its role in cardiac function is poorly understood. To assess the role of TREK-1 in mammalian cardiac function, we interrogated cardiac function in response to pressure overload in global TREK-1 knockout (KO) mice. TREK-1 KO mice showed normal cardiac function in the basal state. However, TREK-1 KO mice developed exaggerated concentric hypertrophy in response to pressure overload. Despite developing exaggerated hypertrophy, TREK-1 KO mice maintained normal systolic and diastolic function as measured by serial echocardiography and invasive hemodynamics. Invasive hemodynamics showed preservation of ventricular compliance in pressure overloaded TREK-1 KO mice, which was associated with significantly attenuated cardiac fibrosis. The limited fibrosis in the heart was indicative of a general impairment of the fibrotic response as measured by impairments in in vivo cutaneous wound healing and in vitro fibroblast migration assays. To determine the mechanism for how TREK-1 modulates fibrosis, we investigated the activation of signaling pathways in lung fibroblasts harvested from TREK-1 KO mice. In response to the profibrotic ligands TGF beta and TNF alpha, TREK-1 KO fibroblasts showed a significantly attenuated activation of the stress-activated kinases p38 alpha and c-Jun N-terminal kinase (JNK), known mediators of myofibroblast activation. These data suggest a critical role for TREK-1 in fibroblast function via the activation of stress-activated kinases. Conclusions: We identified TREK-1 as being critical to the development of diastolic dysfunction and chamber compliance by modulating the signaling pathways involved in the tissue fibrotic response.
- Published
- 2014
- Full Text
- View/download PDF